# Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy

> **NCT03420482** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DRUG:** Fecal Microbiota Transplant (FMT) oral capsules
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03420482
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420482, "Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03420482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*